The truth about drug innovation

Jun 24, 2008

A new report co-authored by Manhattan Institute senior fellow Benjamin Zycher, and Joseph DiMasi, and Christopher-Paul Milne, researchers from the Tufts Center for the Study of Drug Development, examines case histories for thirty-five important pharmaceutical innovations. Skeptics of the private industry assert that the development of new medicines is most attributable to publicly funded sources.

As Marcia Angell, former editor-in-chief of The New England Journal of Medicine, remarked during an interview with PBS News : "Innovation comes mainly from NIH-supported research in academic medical centers. The drug companies do almost no innovation."

In this new study, the authors debunk this assertion and argue that the private sector plays a critical role in drug development.

Key findings include:

-- NIH-sponsored research tends to be concentrated on the basic science of disease biology, biochemistry, and disease processes, the goal of which is to identify biologic targets that might prove vulnerable to drugs yet to be developed.

-- Private sector contributions are weighted heavily toward the applied science of discovering ways to pursue treatments and cures for adverse medical conditions.

The authors conclude that NIH-sponsored and private-sector drug research are complementary to one another and are equally necessary in order to provide patients with better care and treatment.

Source: Tufts University, Health Sciences

Explore further: Maker of device in 'superbug' outbreak lacked FDA clearance (Update)

add to favorites email to friend print save as pdf

Related Stories

'Planck' puts Einstein to the test

1 hour ago

Researchers, including physicists from Heidelberg University, have gained new insights into dark energy and the theory of gravitation by analysing data from the "Planck" satellite mission of the European ...

Professor takes madness out of the month

1 hour ago

With the NCAA Men's and Women's Basketballl Tournaments tipping off soon, brackets and bubble-busters are reaching a fever pitch. Dr. Jay Coleman, the Richard deRaismes Kip Professor of Operations Management and Quantitative ...

New detector sniffs out origins of methane

1 hour ago

Methane is a potent greenhouse gas, second only to carbon dioxide in its capacity to trap heat in Earth's atmosphere for a long time. The gas can originate from lakes and swamps, natural-gas pipelines, deep-sea ...

Distant supernova split four ways by gravitational lens

1 hour ago

Over the past several decades, astronomers have come to realize that the sky is filled with magnifying glasses that allow the study of very distant and faint objects barely visible with even the largest telescopes.

Recommended for you

Breakthrough to take the pain out of catheters

11 hours ago

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

FDA warning: men's testosterone drugs overused (Update)

Mar 03, 2015

The Food and Drug Administration is warning doctors against over-prescribing testosterone-boosting drugs for men, saying the popular treatments have not been established as safe or effective for common age-related ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.